Technology
Health
Pharmaceutical

Aptorum Group

$21.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-2.01%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Aptorum Group and other stocks, options, ETFs, and crypto commission-free!

About APM

Aptorum Group Limited Class A Ordinary Shares, also called Aptorum Group, is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. Read More The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

CEO
Employees
41
Headquarters
Founded
2010
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
2.89K
High Today
$22.39
Low Today
$22.05
Open Price
$22.39
Volume
1.41K
52 Week High
$33.28
52 Week Low
$11.80

Collections

Technology
Health
Pharmaceutical
Therapy
Medical Devices
Medical
2018 IPO

APM Earnings

Q4 2018
Q1 2019
Estimated
Actual
Expected Jul 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.